Photo Acknowledgement: John Welch

Winners of Past Research Grants



Grant Author Location at time of grant Title/Link to publication
2022 $60,000
Dr Sarah Pinto Melbourne The Role of Macrophages in Development and Progression of Type 1 Diabetes Mellitus
2022 $20,000
Dr Gabby Atlas Melbourne Using Whole Genome Sequencing to improve diagnoses for individuals with Differences of Sex Development
2022 $20,000
Dr Lara Graves Sydney Single cell transcriptomic analysis for identification of recombinant adeno-associated virus serotypes for efficient gene delivery to the adrenal cortex
2022 $25,000
Dr Kruthika Narayan Sydney Role of continuous glucose monitoring in presymptomatic type 1 diabetes detected by general population screening,
2022 $15,000
Dr David Cullingford Perth Septo-optic Dysplasia: Aetiology, Burden of Disease and Pathophysiology of Hypopituitarism (SODA BUD)
2022 $25,000 APEG Yoon Hi Cho Sydney Molecular testing in risk stratification of paediatric thyroid nodules of indeterminate pathology
2022 $20,000 APR Paul Benetiz-Aguirre Sydney Investigating long term outcomes of childhood thyroid cancer
$60,000 Pfizer Dr Karissa Ludwig Sydney The diagnosis and characterization of primary bone disorders using urinary stem cells
$25,000 NovoNordisk Dr Tenele Smith Newcastle A cross-over, randomised controlled trial examining the efficacy of OptimAPP, a novel smartphone insulin dose calculator for carbohydrate, fat and protein in managing postprandial glycaemia following ‘problematic foods’ in children and young people with type 1 diabetes using insulin pump therapy
$25,000 APEG Dr Erin Sharwood Queensland Circadian activity rhythm and hormone function, sleep, fatigue and body composition in early survivors of childhood brain tumours
$20,000 Pfizer Dr Martin de Bock Christchurch The effect of non-funded continuous glucose monitoring on health equity in paediatric diabetes in Aotearoa, New Zealand
$15,000 Sandoz Dr Jessica Sandy Sydney ‘Multicentre 24-month Outcome Data on real world use of Burosamab: biochemical, functional, radiological outcomes and acceptability study
$60,000 Pfizer Dr Dana Signal Auckland Specialized dietary intervention in children with type 1 diabetes
$25,000 NovoNordisk Dr Kerry Buchanan Brisbane Markers of endoplasmic reticulum stress in children with recent-onset type 1 diabetes
$15,000 Sandoz Dr Verity Pacey Sydney Development of Allied Health Management Guidelines for Children and Adolescents with Osteogenesis Imperfecta
$15,000 APEG Dr Lucinda Lee Sydney Generating novel AAV vectors for preclinical modelling of gene therapy treatment for diabetes and other endocrine disorders
$10,000 Sanofi Dr Mercedes Burnside Christchurch Addressing the minority Diabetes Divide: A CREATE (Community derived AutomaTEd insulin delivery) Trial Sub-study
$60,000 Pfizer Lara Graves Sydney Genome editing as a therapeutic approach to Congenital Adrenal Hyperplasia
$25,000 NovoNordisk Gabby Atlas Melbourne Disorders of Sex Development:new approaches to improving diagnosis.
Andrew Biggin Sydney Understanding the genetic and cellular mechanisms of reduced bone health caused by obesity
$15,000 APEG Mark de Hora Auckland Bloodspot Steroid Profiling by Liquid Chromatography Mass Spectrometry-Improving clinical outcomes in congenital adrenal hyperplasia.
2019 $10,000 Sanofi Rowen Seckold Newcastle Optimising postprandial Glycaemia in children and young people with Type 1 Diabetes using Hybrid Closed Loop insulin delivery: Current challenges and practical clinical solutions.
2018 $25,000 NovoNordisk Andrew Biggin Sydney Improving height and bone strength in osteogenesis imperfecta using combination growth hormone and bisphosphonate therapy
2018 $15,000 Sandoz Yassmin Musthaffa Brisbane Insights into growth outcomes in paediatric Turner Syndrome from high-throughput transcriptome and epigenome analyses
2018 $15,000 APEG Aveni Haynes Perth Using continuous glucose monitoring (CGM) to characterise early dysglycaemia in young children at risk of Type 1 diabetes
2018 $10,000 Sanofi Sara Boucher Dunedin ‘Flash’ adhesive study: A randomised trial comparing tape and dressings to prolong sensor life in youth using the FreeStyle Libre flash glucose monitoring system
2017 $25,000 Novo Nordisk Prudence Lopez Newcastle Defining the optimal insulin management for high fat and protein meals in children and young people with Type 1 Diabetes (T1D) using multiple daily insulin injection (MDI) therapy
2017 $15,000 Sandoz Matthew Sabin Melbourne CardioMetabolicRisk in Youth Obesity: investigating growth trajectories for later disease – The COBRA-CMR study
2017 $10,000 Sanofi Benjamin Wheeler Dunedin Sleep disturbances in parents of children diagnosed with type 1 diabetes
2017 $10,000 APEG Ashleigh Lin Perth Characterising fluctuations in stress, anxiety and blood glucose levels in adolescents with type 1 diabetes
2016 $25,000 Novo Nordisk Carmel Smart Newcastle Establishment of an insulin dosing schedule for high fat, high protein meals in individuals with type 1 diabetes using insulin pump therapy
2016 $10,000 APEG Karen Rothacker Perth The effect of hyperglycaemia in standard and low insulin states on exercise performance compared to exercise performance in euglycaemia
 2016 $15,000 Sandoz Rebecca Pelekanos Brisbane Developing a multifaceted molecular pipeline to predict good and poor responders to recombinant growth hormone therapy
2015 $25,000 NovoNordisk Paul Hofman Auckland Does subclinical congenital hypothyroidism cause long term cognitive impairment?
2015 $15,000 Sandoz Ian Hughes Brisbane Relationships between IGF-1 Values and Growth Hormone Dose and Response to Treatment in Children Treated Under the Australian Growth Hormone Program: An OZGROW Analysis?
2014 $25,000 NovoNordisk Tim Jones Perth Neurocognitive development of children and adolescents with type 1 diabetes mellitus
2014 $10,000 Merck Serono Denise Steers Wellington Gender bender, mender or defender? Disorder of sex development –Navigating clinical decision making in New Zealand
2014 $10,000 SciGen Stephanie Johnson Brisbane To determine the prevalence of MODY in a paediatric diabetes population using Next Generation Sequencing
2014 $15,000
Eli Lilly
Tony Huynh Brisbane The establishment of HPLC-MS/MS-based dried blood spot 17-OHP target ranges for glucocorticoid dose adjustment in children with Congenital Adrenal Hyperplasia
2013 $25,000 Novo Nordisk Carmel Smart Newcastle A comparison of three insulin dosage algorithms for meals of variable macronutrient composition on postpranial glucose levels in children with type 1 diabetes
2013 $10,000 SciGen Grant Penny Jeffrey Brisbane Appetite hormone regulation in Prader-Will Syndrome
2012 $25,000 Novo Nordisk Jacqueline Hewitt Melbourne Understanding the cause of testicular regression syndrome through whole exome sequencing and gene functional analysis
2012 $25,000 Novo Nordisk Yoon Hi Cho Sydney Impact of weight gain and insulin resistance on vascular health of adolescents with type 1 diabetes
2012 $15,000
Eli Lilly
Fergus Cameron Melbourne A randomised controlled trial of the impact of a case management programme as compared with usual care in the transition of young adults with type 1 diabetes mellitus from paediatric to adult services
2012 $10,000 Ipsen Maria Craig Sydney Enterovirus infection and vitamin D status at the onset of type 1 diabetes
2011 $15,000
Eli Lilly
Ahila Ayyavoo Auckland The childhood consequences of hyperemesis gravidarum
2011 $15,000 Merck Ian Hughes Brisbane GH Therapy in Prader-Willi Syndrome
2011 $10,000 Ipsen Liz Davis Perth Improving insulin sensitivity and vascular function in adolescents with type 2 diabetes using a 12 week supervised exercise intervention: a randomised control trial
2011 $15,000 Sanofi Silmara Gusso Auckland Does whole body vibration improve body composition and motor function in children with mild to moderate cerebral palsy?
2011 $25,000 Novo Nordisk Tim Jones Perth Neurocognitive outcomes of children with type 1 diabetes mellitus
2010 $15,000 Merck Serono Ann Maguire Sydney Gonadal status and hormone replacement in survivors of childhood bone marrow Transplant (no publication written)
2009 $10,000 Eli Lilly Margaret Zacharin Melbourne Clinical trial of Zoledronic acid (Aclasta) in children and adolescents with Duchenne Muscular Dystrophy
2009 $15,000 Merck Peter Simm Melbourne The exploration of candidate genes involved in the novel interaction between IGF-1 and FGF2 in an in vitro model of growth plate chondrogenesis